Last reviewed · How we verify

NCT05940025

Multidisciplinary Digital Therapeutics of Chronic Lower Back Pain Versus Usual Care

Completed NA Last updated 31 July 2024
What this trial tests

NA trial testing MORT-LBP in Chronic Low-back Pain in 46 participants. Completed in 4 April 2024.

Timeline
16 August 2023
Primary endpoint
4 April 2024
4 April 2024

Quick facts

Lead sponsorEverEx Inc.
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment46
Start date16 August 2023
Primary completion4 April 2024
Estimated completion4 April 2024
Sites2 locations across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

EverEx Inc. — full company profile →

Who can join

Adults 19 to 65, any sex, with Chronic Low-back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This randomized controlled pilot study will be evaluating an app, MORT-LBP app (ETH-02K), owned by EverEx, Inc., to examine safety and efficacy in individuals with chronic lower back pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Chronic Low-back Pain

Currently open trials in the same condition.

Other EverEx Inc. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05940025.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing